The rapid rise of infectious and resistant organisms has rendered standard antibiotics ineffective for many common conditions - and it's wreaking havoc on both patient safety and the bottom line for hospitals.
To combat the growing risk, national regulatory initiatives have been upping the ante on an effective response from the healthcare community. Against that backdrop lies an increasingly value-based reimbursement environment, making both the delivery of quality care and improvement in patient outcomes essential to a healthcare organization’s positive financial performance.
